Synthetic resins or natural rubbers -- part of the class 520 ser – Synthetic resins – From phenol – phenol ether – or inorganic phenolate
Reexamination Certificate
2011-03-22
2011-03-22
Boykin, Terressa M (Department: 1765)
Synthetic resins or natural rubbers -- part of the class 520 ser
Synthetic resins
From phenol, phenol ether, or inorganic phenolate
C424S078270, C424S078320, C435S068100, C435S071100, C514S008100, C528S198000, C530S351000, C530S397000
Reexamination Certificate
active
07910685
ABSTRACT:
Conjugates between a protein and a water soluble polymer comprising multiple degradable carbonate linkages are provided.
REFERENCES:
patent: 4670417 (1987-06-01), Iwasaki et al.
patent: 5252714 (1993-10-01), Harris et al.
patent: 5281698 (1994-01-01), Nitecki
patent: 5463012 (1995-10-01), Ferruti et al.
patent: 5468478 (1995-11-01), Saifer et al.
patent: 5650234 (1997-07-01), Dolence et al.
patent: 5672662 (1997-09-01), Harris et al.
patent: 5824784 (1998-10-01), Kinstler et al.
patent: 5900461 (1999-05-01), Harris
patent: 5932462 (1999-08-01), Harris et al.
patent: 6348558 (2002-02-01), Harris et al.
patent: 6362254 (2002-03-01), Harris et al.
patent: 6432397 (2002-08-01), Harris
patent: 6610281 (2003-08-01), Harris
patent: 7074878 (2006-07-01), Harris et al.
patent: 7259224 (2007-08-01), Harris et al.
patent: 7608678 (2009-10-01), Harris et al.
patent: 7772357 (2010-08-01), Harris et al.
patent: 2007/0276116 (2007-11-01), Harris et al.
patent: 2010/0004392 (2010-01-01), Harris et al.
patent: WO 99/55760 (1999-11-01), None
Abuchowski, et al., “Cancer Therapy with Chemically Modified Enzymes. I. Antitumor Properties of Polyethylene Glycol-Asparaginase Conjugates,” Cancer Biochem. Biophys., vol. 7, pp. 175-186 (1984).
Andresz, et al., “Chemische Synthese verzweigter Polysaccharide 5*,” Makromol. Chem., 179, pp. 301-312 (1978).
Beauchamp, et al., “A New Procedure for the Synthesis of Polyethylene Glycol-Protein Adducts: Effects on Function, Receptor Recognition, and Clearance of Superoxide Dismutase, Lactoferrin, and α2-Macroglobulin,” Anal. Biochem., 131, pp. 25-33 (1983).
Buckman, et al., “Functionalization of Poly(ethylene glycol) and Monomethoxy-Poly(ethylene glycol),” Makromol. Chem., 182, pp. 1379-1384 (1981).
Elling, et al., “Immunoaffinity Partitioning: Synthesis and Use of Polyethylene Glycol-Oxirane for Coupling to Bovine Serum Albumin and Monoclonal Antibodies,” Biotech. and Appl. Biochem., 13, pp. 354-362 (1991).
Goodson, et al., “Site-Directed Pegylation of Recombinant Interleukin-2 at its Glycosylation Site,” Bio/Technology, vol. 8, pp. 343-346 (Apr. 1990).
Harris, et al., “Synthesis and Characterization of Poly(Ethylene Glycol) Derivatives,” J. Polym. Sci., vol. 22, pp. 341-352 (1984).
Joppich, et al., “Peptides Flanked by Two Polymer Chains,1—Synthesis of Glycyl-L-tryptophylglycine Substituted by Poly(ethylene oxide) at both the Carboxy and the Amino End Groups,” Makromol. Chem., 180, pp. 1381-1384 (1979).
Kogan, “The Synthesis of Substituted Methoxy-Poly(Ethylene Glycol) Derivatives Suitable for Selective Protein Modification,” Synthetic Communications, 22(16), pp. 2417-2424 (1992).
Olson, et al., “Preparation and Characterization of Poly(ethylene glycol)ylated Human Growth Hormone Antagonist,” Poly(ethylene glycol) Chemistry and Biological Applications, pp. 170-181, Harris & Zalipsky Eds., ACS, Washington, D.C. (1997).
Ouchi, et al., “Design of Antitumor Agent-Terminated Poly(Ethylene Glycol) Conjugate as Macromolecular Prodrug,” Polymer Preprints, vol. 38, No. 1, pp. 582-583 (Apr. 1997).
Pitha, et al., “Detergents Linked to Polysaccharides: Preparation and Effects on Membranes and Cells,” Eur. J. Biochem., 94, pp. 11-18 (1979).
Romani, et al., “Synthesis of Unsymmetrical Cystine Peptides: Directed Disulfide Pairing with the Sulfenohydrazide Method,” Chemistry of Peptides and Proteins, vol. 2, pp. 29-34 (1984).
Sartore, et al., “Enzyme Modification by MPEG with an Amino Acid or Peptide as Spacer Arms,” Appl. Biochem. and Biotech., vol. 27, pp. 45-54 (1991).
Sawhney, et al. “Bioerodible Hydrogels Based on Photopolymerized Poly(ethylene glycol)-co-poly(α-hydroxy acid) Diacrylate Macromers,” Macromolecules, vol. 26, No. 4, pp. 581-587 (1993).
Tondelli, et al., “Poly(Ethylene Glycol) Imidazolyl Formates as Oligomeric Drug-Binding Matrices,” J. Controlled Release, 1, pp. 251-257 (1985).
Veronese, et al., “Surface Modifications of Proteins—Activation of Monomethoxy-Polyethylene Glycols by Phenylchloroformates and Modification of Ribonuclease and Superoxide Dismutase,” Appl. Biochem. and Biotech., vol. 11, pp. 141-152 (1985).
Woghiren, et al., “Protected Thiol-Polyethylene Glycol: A New Activated Polymer for Reversible Protein Modification,” Bioconj. Chem., vol. 4, No. 5, pp. 314-318 (1993).
Zalipsky, et al., “Attachment of Drugs to Polyethylene Glycols,” Eur. Polym. J., vol. 19, No. 12, pp. 1177-1183 (1983).
Enzon Pharmaceuticals, Macromolecular Engineering Technologies, pp. 1-14, (2004).
Nektar™—Transforming Therapeutics, Nektar Molecule Engineering: Polyethylene Glycol and Derivatives for Advanced PEGylation, pp. 1-20, Catalog—2003, (Jul. 2003).
Nektar™—Transforming Therapeutics, Nektar Advanced PEGylation: Polyethylene Glycol and Derivatives for Advanced PEGylation, pp. 1-24, Catalog—2004, (Jul. 2004).
NOF Corporation, “PEG Derivatives, Phospholipid and Drug Delivery Materials for Pharmaceuticals”, pp. 1-46, Catalogue 2003-1st, (Jan. 2003).
NOF Corporation, “PEG Derivatives, Phospholipid and Drug Delivery Materials for Pharmaceuticals”, pp. 1-50, Catalogue 2003-2nd, (Mar. 2004).
NOF Corporation, PEG Derivatives Phospholipid and Drug Delivery Materials for Pharmaceuticals, pp. 2-59 (Catalog Version 8 Apr. 2006).
Polypure—products listing, pp. 1-5, (Apr. 2004).
Polypure—products listing, pp. 1-5, (Apr. 2005).
Quanta Biodesign, Labeling, Derivatization and Crosslinking Reagents for Biological and Related Materials with dPEG™, pp. 2-38 (Catalog—Mar. 2004).
Quanta Biodesign, Labeling, Derivatization and Crosslinking Reagents incorporating our unique monodispersed dPEG™ Technology, pp. 2-31 (Catalog—Nov. 2004).
Quanta Biodesign, Inc., Product Catalog, pp. 1-51 (Catalog Jul. 2005).
Quanta Biodesign, Inc., Product Catalog, pp. 1-51 (Catalog Nov. 2005).
Shearwater Polymers, Inc., Polyethylene Glycol and Derivatives, pp. 1-49, (Catalog—Mar. 1995).
Shearwater Polymers, Inc., Polyethylene Glycol and Derivatives, pp. 1-53, (Catalog—Jul. 1997).
Shearwater Polymers, Inc., Polyethylene Glycol and Derivatives: Functionalized Biocompatible Polymers for Research and Pharmaceuticals, pp. 1-50, (Catalog—Jan. 2000).
Shearwater Corporation, Polyethylene Glycol and Derivatives for Biomedical Applications, pp. 1-17, (Catalog—Jul. 2001).
Bentley Michael D.
Harris J. Milton
Shen Xiaoming
Zhao Xuan
Boykin Terressa M
Nektar Therapeutics
Wilson Mark A.
LandOfFree
Hydrolytically degradable polymers and hydrogels made therefrom does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrolytically degradable polymers and hydrogels made therefrom, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrolytically degradable polymers and hydrogels made therefrom will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2720424